Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Nanomaterial for Adjuvants Vaccine: Practical Applications and Prospects

Indonesian Journal of Chemistry · Vol. 24 No. 1 (2024) · hlm. 284–284

DOI
10.22146/ijc.87940
ISSN
1411-9420, 2460-1578
Terbit
2024-02-01
Penerbit
Gadjah Mada University
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc-nd/4.0/

Abstrak

Vaccines contain adjuvants to strengthen the immune responses of the receiver against pathogen infection or malignancy. A new generation of adjuvants is being developed to give more robust antigen-specific responses, specific types of immune responses, and a high margin of safety. By changing the physical and chemical properties of nanomaterials, it is possible to make antigen-delivery systems with high bioavailability, controlled and sustained release patterns, and the ability to target and image. Nanomaterials can modulate the immune system so that cellular and humoral immune responses more closely resemble those desired. The use of nanoparticles as adjuvants is believed to significantly improve the immunological outcomes of vaccination because of the combination of their immunomodulatory and delivery effects. In this review, we discuss the recent developments in new adjuvants using nanomaterials. Based on three main vaccines, the subunit, DNA, and RNA vaccines, the possible ways that nanomaterials change the immune responses caused by vaccines, such as a charge on the surface or a change to the surface, and how they affect the immunological results have been studied. This study aims to provide succinct information on the use of nanomaterials for COVID-19 vaccines and possible new applications.

Kata kunci

Jaringan kolaborasi para penulis

12 penulis · 36 tautan kepenulisan bersama · 21 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Industrial University of Ho Chi Minh City
  • Trường ĐH Nguyễn Tất Thành
  • Quy Nhon University
  • Ho Chi Minh City University of Science
  • University of Medicine and Pharmacy at Ho Chi Minh City
  • Ministry of Education and Training
  • Duy Tan University
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Hoang Ai Le PhamIndustrial University of Ho Chi Minh City1
Nguyen Van CuongIndustrial University of Ho Chi Minh City1
Trần Thị Lan AnhIndustrial University of Ho Chi Minh City1
Pham Tan VietIndustrial University of Ho Chi Minh City1
Nguyễn Thị Lan HươngIndustrial University of Ho Chi Minh City1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764840418, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Nanomaterial for Adjuvants Vaccine: Practical Applications and Prospects</dc:title><dc:creator>Vy Anh Tran</dc:creator><dc:creator>Vien Vo</dc:creator><dc:creator>Vinh Quang Dang</dc:creator><dc:creator>Giang N. L. Vo</dc:creator><dc:creator>Tạ Ngọc Đôn</dc:creator><dc:creator>Van‐Dat Doan</dc:creator><dc:creator>Van Thuan Le</dc:creator><dc:subject>vaccine adjuvants</dc:subject><dc:subject>nanomaterials</dc:subject><dc:subject>nanoparticles</dc:subject><dc:subject>immunomodulation</dc:subject><dc:subject>antigen delivery</dc:subject><dc:subject>sustained drug release</dc:subject><dc:subject>surface charge</dc:subject><dc:subject>subunit vaccine</dc:subject><dc:subject>DNA vaccine</dc:subject><dc:subject>RNA vaccines</dc:subject><dc:subject>COVID-19 vaccines</dc:subject><dc:subject>humoral and cellular immune response</dc:subject><dc:description xml:lang="en">Vaccines contain adjuvants to strengthen the immune responses of the receiver against pathogen infection or malignancy. A new generation of adjuvants is being developed to give more robust antigen-specific responses, specific types of immune responses, and a high margin of safety. By changing the physical and chemical properties of nanomaterials, it is possible to make antigen-delivery systems with high bioavailability, controlled and sustained release patterns, and the ability to target and image. Nanomaterials can modulate the immune system so that cellular and humoral immune responses more closely resemble those desired. The use of nanoparticles as adjuvants is believed to significantly improve the immunological outcomes of vaccination because of the combination of their immunomodulatory and delivery effects. In this review, we discuss the recent developments in new adjuvants using nanomaterials. Based on three main vaccines, the subunit, DNA, and RNA vaccines, the possible ways that nanomaterials change the immune responses caused by vaccines, such as a charge on the surface or a change to the surface, and how they affect the immunological results have been studied. This study aims to provide succinct information on the use of nanomaterials for COVID-19 vaccines and possible new applications.</dc:description><dc:publisher>Gadjah Mada University</dc:publisher><dc:date>2024-02-01</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.22146/ijc.87940</dc:identifier><dc:identifier>10.22146/ijc.87940</dc:identifier><dc:source>Indonesian Journal of Chemistry; Vol 24 No 1 (2024); 284-284</dc:source><dc:source>1411-9420</dc:source><dc:source>2460-1578</dc:source><dc:language>en</dc:language><dc:relation>https://jurnal.ugm.ac.id/ijc/article/download/87940/37732</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights></oai_dc:dc>